A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

NCT05703204 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia and Myelodysplastic Syndrome

Interventions

DRUG: QLF32101

Sponsor

Qilu Pharmaceutical Co., Ltd.